DCM
PRTA icon

Driehaus Capital Management’s Prothena Corp PRTA Stock Holding History

Driehaus Capital Management’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-25,000
Closed -$396K – 512
2019
Q4 		$396K Buy
+25,000
New +$268K 0.01% 428

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Driehaus Capital Management's PRTA Position: Q1 2020 in Review

Driehaus Capital Management sold out of Prothena Corp (PRTA) in Q1 2020, closing a stake of 25,000 shares — an estimated $396K sold.

Driehaus Capital Management first reported a position in PRTA in Q4 2019 and held it in 1 quarter. The position peaked at $396K in Q4 2019. 129 funds tracked by Wall St. Rank hold PRTA as of Q1 2020.

  • Driehaus Capital Management reported no remaining Prothena Corp position as of Q1 2020 after selling out during the quarter.
  • Driehaus Capital Management sold 25,000 Prothena Corp shares in Q1 2020, an estimated $396K.
  • Driehaus Capital Management first reported a position in Prothena Corp in Q4 2019 and held it in 1 quarter.
  • Driehaus Capital Management's Prothena Corp position peaked at $396K in Q4 2019.
  • 129 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2020.

Based on Driehaus Capital Management's 13F filing for Q1 2020, filed 15 May 2020.